Metformin Protects H9C2 Cardiomyocytes from High-Glucose and Hypoxia/Reoxygenation Injury via Inhibition of Reactive Oxygen Species Generation and Inflammatory Responses: Role of AMPK and JNK

Metformin is a first-line drug for the management of type 2 diabetes. Recent studies suggested cardioprotective effects of metformin against ischemia/reperfusion injury. However, it remains elusive whether metformin provides direct protection against hypoxia/reoxygenation (H/R) injury in cardiomyocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Mingyan, Ye, Ping, Liao, Hua, Chen, Manhua, Yang, Feiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884853/
https://www.ncbi.nlm.nih.gov/pubmed/27294149
http://dx.doi.org/10.1155/2016/2961954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884853/
https://www.ncbi.nlm.nih.gov/pubmed/27294149
http://dx.doi.org/10.1155/2016/2961954

Ejemplares similares